Fox Chase Cancer Center researchers have identified a way forward for personalized cancer treatments for a wide range of cancers. Their findings can provide new insight into the mechanisms of a small molecule and investigational new drug for cancer ca...

From Prevention Matters Newsletter, Spring 2016 [PDF] By Elias Obeid, MD, MPH Metastatic castration-resistant prostate cancer (mCRPC) is when the cancer has spread to parts of the body other than the prostate, and is able to grow and spread despite tre...

If the lymphoma comes back (relapses) after having received a stem cell transplant, treatment options are very limited. Treatment of a post-transplant relapse is further complicated by residual side effects related to the transplant. In the world of bone...

My research staff and I at Fox Chase Cancer Center have recently launched a new study called PROGRESS (Prostate Cancer Online Guide& Resources for Electronic Survivorship Service) for men who have completed prostate cancer treatment within the last year...

The recent work of The Cancer Genome Atlas (TCGA) showing the underlying genetic changes for kidney cancer is groundbreaking, and it will lead to major progress in kidney cancer treatment (see related blog). But another exciting new therapy is already av...

A article in yesterday’s New York Times (“Cancer Centers Racing to Map Patients’ Genes,” April 21, 2013) discusses the emerging importance of gene mapping in determining precise medical treatment.Fox Chase Cancer Center has been pursuing this course of...